Shivani Raja

RESEARCH - RESILIENCE is the UKs Medicines Manufacturing Skills Centre of Excellence addressing talent gaps across the sector by working in partnership with industry and educators. Medicines manufacturing is the largest contributor to the UK economy within the life sciences sector - according to Medicines Manufacturing Industry Partnership report (2023): Follow the Green High Tech Road: A path to UK growth, net zero and health resilience from innovation in medicines manufacturing (published in partnership with industry & UK Government). The UK has a global leading position across many emerging and established technology areas in early research and discovery, but it is manufacturing that delivers the largest share of jobs - https://lnkd.in/eRqsxZYd With significant advances in technology for medicines manufacturing requiring up to date knowledge of both established technologies and new modalities, application of digital and automation skills and professional behaviours to be able to adapt to change, attracting new entrants to the sector and upskilling existing staff are fundamental to the talent pipeline and economic productivity of the UK. To find out more on quality assured training opportunities to attract talent and upskill with RESILIENCE centres in the UK - University of Birmingham, UCL, Teesside University and Heriot-Watt University IBioIC and Britest Limited - Click here ➡ https://lnkd.in/eimTzSsJ Ivan Wall Gary Lye Prof Muhammad Safwan Akram Nik Willoughby Bernice Wright Laura Porcza Neil Renault Connor Foster Professor Vikki Rand Laura Bennett (nee Unitt) Tony Bradshaw Kate Barclay Deepak Verma Emma Maun John Henderson Reshma Nazeer, Ph.D. #RESILIENCE #UKmedsmanufacturing #manufacturingskills

23

1 Comment

What sets BRILLIANT apart as an Education Event? I spoke to Andrew Croydon of The Association of the British Pharmaceutical Industry (ABPI) and asked him about their reasons for being involved. 1. Motivation for Attending:  "We are excited to attend the BRILLIANT Early Years to Careers event because it provides a unique opportunity to connect with educators and extend our commitment to invest in education as an investment in the future ."   2. Hopes for Achievement:  "By participating in this event, we hope to inspire teachers with our broad STEM education resources, alongside insights into the pharmaceutical industry, to help teachers better inform and motivate their students about career opportunities in this field."   3. Benefits for Teachers:  "This event is a fantastic platform for teachers to gain a deeper understanding of an innovation-based industry, learning about the industry’s latest advancements and key initiatives, and discovering how to incorporate this knowledge into curricula to inspire the next generation."   4. Message to Teachers:  "We want teachers to know that our UK pharmaceutical sector is committed to pioneering new treatments and improving lives. We believe that by sharing our work and passion, we can help educators inspire students to pursue rewarding careers based on informed choices."   At BRILLIANT, we create a unique space where industry leaders and educators come together. This collaboration is vital for bridging the gap between current educational practices and future job market needs. Our goal is to prepare children for the jobs of tomorrow. By aligning educational strategies with industry demands, we ensure that students acquire the critical skills required in priority sectors. My message to other industry leaders ... Be part of it! www.brilliantfestival.com

16

1 Comment

Around 100,000 people in the UK are affected by alopecia. In a new article we explore alopecia areata, a type of alopecia that is thought to be an autoimmune disease. Learn more. ⤵️ #PfizerUK

3

Here is a detailed article by our tutor Hannah Sandhu covering how to get started with your preparation for a medical or biomedical interview at Oxbridge! https://lnkd.in/e35eNGg8

9

1 Comment

Representing RESILIENCE today Kate Barclay presented two apprenticeship workshops at The Priory School in Hertfordshire inspiring Year 12 students to investigate alternative career pathways in to life sciences and medicines manufacturing. Key takeaways: 👩‍🔬 There is still limited knowledge out there amongst students about apprenticeships across STEM with the overwhelming majority considering university as the only way to access these careers. 👩‍🔬 Students really want to know more about alternative pathways to weigh up their career choices with as much information as they can get hold of to make informed decisions. 👩‍🔬 Applying for apprenticeships is a minefield compared to university places with significant competition for limited places, complex and lengthy application processes at a time when revising for exams is stressful enough. Students were so keen to know more - with one student quoting 'I was looking for a way to combine studying and working in a lab and this is ideal, I didn't know so much was on my doorstep' If you are a school or college and want to know more about RESILIENCE - UK Medicines Manufacturing Skills Centre of Excellence ➡ https://lnkd.in/eimTzSsJ Ivan Wall Gary Lye Nik Willoughby Bernice Wright Laura Bennett (nee Unitt) Deepak Verma Neil Renault Laura Porcza Prof Muhammad Safwan Akram Connor Foster Emma Maun

25

1 Comment

Ainsley is studying the T Level in Laboratory Sciences! He chose this course because it offers a practical and hands-on approach that aligns with his interests and career goals. Talking about his T Level, he said: "My favourite part has been the support I’ve received. The teachers have really pushed me out of my comfort zone, and as a result, I’ve achieved grades that I never expected." 🙏 👀 Want to follow in Ainsley's footsteps? Explore out T Level courses at https://lnkd.in/eARPuYeq #TLevelsWeek

1

In the UK, one in two of us will get cancer in our lifetime. Immunotherapy can help treat cancer by enhancing the immune system’s ability to fight cancer cells or directly attacking cancer cells. In our upcoming webinar aimed at healthcare professionals, those supporting people with cancer and cancer patients, experts discuss the impact of immunotherapy, and the increasing success. Register now: bit.ly/3NBd5Om #CancerTreatment #Immunotherapy #Webinar

26

What’s at stake for the NHS from the policies of an incoming Government?   Well, there are £18bn in potential NHS savings on the table from the 255 medicines due to come off patent over the next five years. These will only be realised with proactive, supportive policy for the generic and biosimilar sector.   Read our manifesto to discover how a more favourable policy environment can unlock these savings: https://bit.ly/3IRxzAd   #NHSdrugsbill #healthpolicy #generics #biosimilars

30

As the new government takes office, Antibiotic Research* extends its congratulations and stands ready to collaborate on addressing one of the most pressing public health challenges of our time: antimicrobial resistance (AMR). Our mission is to protect current and future generations from drug-resistant infections through research, education, and patient support. We look forward to working with the new administration to ensure that the fight against AMR remains a top priority on the national health agenda, and that they continue to support the newly rolled out National Action Plan. #AMR Key Policy Recommendations here: https://bit.ly/3RSAUEc

69

Monday morning funding round up of current health and life sciences opportunities! A new funding opportunity in collaboration with BBSRC to support scientists has been announced https://lnkd.in/eiD9efpJ   Ulster Bank is making 150 places available on the next intake of its fully funded accelerator. https://lnkd.in/eBwssaJ2   KQ Labs is a tailored accelerator programme devoted to helping start-ups transform healthcare through data-driven solutions. https://lnkd.in/eRdatyVy   New competitions from SBRI Healthcare opening this month: Antimicrobial Resistance (AMR) and Women’s Health This competition offers contracts for technical and commercial feasibility studies, valued at up to £100,000 for six months. The AMR segment seeks innovations in point of care diagnostics, monitoring, susceptibility testing, prescribing decision support, risk stratification, novel care delivery methods, and infection prevention and control. The Women’s Health call targets gynaecological conditions, hormonal health, mental health, chronic conditions, and long-term health. Urgent & Emergency Care, and Stroke This competition offers contracts for the collection of evidence in real-world settings, with funding of up to £500,000 for a maximum period of 12 months https://lnkd.in/efDw_sqH   The MRC Centre of Research Excellence (MRC CoRE) funding is used to tackle complex and interdisciplinary health challenges. This is an annual funding opportunity. MRC CoREs will be funded for up to 14 years. Your award will initially last for seven years, with a further seven years based on successful review. The full economic cost (FEC) of your MRC CoRE can be up to £26.25 million for the first seven years. The maximum MRC contribution is £21 million. https://lnkd.in/e5S8C_sF   The Global Health Research (GHR) – Researcher-led programmes are looking for applications to a new, annual funding opportunity. https://lnkd.in/e3CZV83k   Apply for funding to develop novel tools and technologies to enable people to live independently with dementia. https://lnkd.in/ez_WuMDX   Apply for support to become an internationally recognised research leader in your field. Your research can focus on any area of Medical Research Council’s (MRC) remit to improve human health. https://lnkd.in/eHn7V3ZD  

7

2 Comments

Innovate UK and Office for Life Sciences (OLS) have announced the names of six more Advancing Precision Medicine cancer projects to receive funding. Precision medicine offers new ways of treating disease by tailoring treatments to the individual patient and can enable earlier and more accurate diagnosis of diseases, including cancer. The six projects funded by Innovate UK and OLS are intended to improve patient outcomes by developing innovative technologies to enable faster, safer and more accurate diagnosis, and direct patients towards the most appropriate treatments. The projects also focus on developing partnerships between industry-led teams, the NHS and academia to accelerate cancer research innovation and drive growth within the life sciences sector. The successful projects are: - Concr, Durham University and The Institute of Cancer Research Artificial intelligence (AI)-VISION: an observational study validating a predictive algorithm integrating multi-modal data for patient prognostication and treatment stratification in triple negative breast cancer. - Eliptica and The University of Edinburgh AIPIR: development of an advanced AI proteomic platform to identify, track and predict host response to solid tumour immunotherapies. - Exogene and OutSee ST T-cell receptor: unlocking the discovery of novel shared targets and T-cell receptors for precision cancer therapies. - Mirada Medical, Leeds Teaching Hospitals NHS Trust and University of Bristol End-to end AI-assisted workflow for prostate-specific membrane antigen positron emission tomography or computed tomography reporting. - Signatur Biosciences and University of Oxford Revolutionising breast cancer prognosis with OncoSignatur: an innovative, cost-effective quantitative polymerase chain reaction profiling test for improved, personalised patient pathways. - Spotlight Pathology and Leeds Teaching Hospitals NHS Trust AI digital diagnostics platform to streamline the diagnosis of blood cancers. This announcement follows the recent commitment from the Department for Science, Innovation and Technology for £146 million to support cancer diagnosis and treatment 🔗 https://ow.ly/vyUq50THASW Read more on the Advancing Precision Medicine grant winners 🔗 https://ow.ly/1wwn50THASX

51

🧬 Are you working on drug discovery or precision medicine in the UK? 💊 💻 Are you interested in fully-funded access to advanced computing resources and expert support from STFC and IBM? 👉 Send us your expressions of interest for our Innovation in Life Sciences Sector Call by 29 Nov 2024! 🖱️ Find out more and apply here: https://orlo.uk/26owI Francis Lee | Paul Steward | Deb Clayton #FundingOpp #LifeSciences #Innovation #DigitalTechnology #PrecisionMedicine #DrugDiscovery #DigitalInnovation #DataScience #AI

1

Have you been impacted by medicine shortages? Our colleagues at National Voices are looking at the impact of medical shortages on people and communities across the UK. If this has effected you then you may want to complete this survey and share your experience - https://ow.ly/umck50RMT9O

1

The PACE AMR diagnostics call is open 📢 PACE (Pathways to Antimicrobial Clinical Efficacy) is a collaboration between Innovate UK, LifeArc and Medicines Discovery Catapult, which aims to accelerate early-stage translational innovation to tackle antimicrobial resistance (AMR). The UK’s life sciences research base is world leading and we encourage anyone in the UK with an innovative AMR diagnostics project to find out more. Why? AMR is one of the top 10 global public health threats and an urgent global challenge. According to a 2022 study published in The Lancet, 1.27 million deaths worldwide were attributable to infections caused by bacterial AMR in 2019. The UK Review on Antimicrobial Resistance has estimated this will rise to 10 million people every year by 2050. Without effective antimicrobials and better, quicker ways to diagnose microbial infections, the success of modern medicine in treating infections, including during major surgery and cancer chemotherapy, would be at increased risk. Please share this post with everyone in your network working in this area. Learn more and sign up to the PACE-AMR webinar 🔗 https://ow.ly/cO5f50Tw4el #Funding #ProductDevelopment #AntimicrobialResistance #AMR #Diagnostics

36

2 Comments

Asthma and Lung UK and Sanofi are committed to supporting healthcare professionals in providing the highest quality care for COPD patients. Through education, collaboration, and advocacy, we aim to equip clinicians with the tools they need to optimize patient outcomes. Our ambition is for people to #BreatheEqual, to see improvements in the recognition, diagnosis and quality of care for those suffering with respiratory conditions, regardless of location and socio-economic status. See our mission statement here: https://lnkd.in/eVBAsVpc Asthma + Lung UK (asthmaandlung.org.uk)

28

We are pleased to be partnering with Prostate Cancer Research to work on making the case for a prostate cancer screening programme in the UK: https://lnkd.in/e_aRgZyu Prostate Cancer Research is a charity dedicated to funding research aimed at preventing, diagnosing, and treating prostate cancer. They focus on innovative scientific research to improve outcomes and quality of life for those affected by the disease. Through fundraising efforts and collaboration with scientists and medical professionals, they strive to advance understanding of prostate cancer and develop more effective treatments and interventions. PCR Screening Petition Every year over 13,000 men die of prostate cancer - that's one every 40 minutes. This is a national tragedy. It doesn’t need to be this way. If prostate cancer is caught early it is almost always curable. It is time prostate cancer was prioritised in this country. As you read this, the major political parties are finalising their manifestos, deciding what to include and what not to include if they win the next election. Join us and demand that political parties commit to introducing prostate cancer screening in the next Parliament. Will you sign up and join our movement? We need to speak as one voice and make ourselves heard. Your signature can make a difference. It is time for action. Add your signature today and help save lives. To sign our screening petition, visit: https://lnkd.in/er6AZmzN

10

Join us to explore how we can collectively build a more trustworthy and impactful #health system and elevate the UK #LifeSciences sector. Recent studies in the UK have highlighted public sentiments when it comes to #vaccines and #clinicalresearch. Understanding public concerns about vaccines is crucial, as effective communication and trust-building can help individuals make informed health decisions. Clinical research plays a crucial role in providing #evidence on vaccine safety and efficacy, which reinforces #public #confidence. To enhance vaccine uptake and address hesitancy, collaboration between health authorities and researchers is vital. At this summit, we will address these critical issues through expert panels and insightful discussions aimed at building a more #trustworthy and #effective health system. 🎟 Secure your spot: https://lnkd.in/dFjdpjYB White City Innovation District Hammersmith & Fulham Council Imperial College Chemistry Society Imperial Enterprise Imperial College Bioengineering Society I-HUB Scale Space I-X UKTN Blenheim Chalcot Imperial College Advanced Hackspace Imperial Enterprise Lab Mary Ryan Oscar Ces Startup Grind Impact Hub Network Huckletree Royce at Imperial #JawdropFireside24 #HealthOutcomes #LifeSciences #TrustInHealthcare #UKHealth #VaccineHesitancy

4